Results 111 to 120 of about 4,785,295 (305)
Open letter: A global call to strengthen national soil biodiversity action through coordination and harmonization
Plants, People, PlanetSoil biodiversity remains one of the least systematically studied components of global biodiversity, largely invisible in policy agendas. A coordinated soil biodiversity monitoring approach is urgently needed to enable national‐level action.César Marín, Carlos Barreto, Brajesh K. Singh, Peter C. deRuiter, George G. Brown, Jeff Battigelli, Gian Luca Bagnara, Rosalina González, Carlos Guerra, Xin Sun, Tara Dirilgen, Jacob Ulzen, Giulio Malorgio, Luca Montanarella, Claudia Coleine, Leena Vilonen, J. Jacob Parnell, Joseph Edwards, Heba Alfares, Gandhiv Kafle, Nasradeen A. H. Gadallah, Hannah Karuri, Arindam Roy, Edward Yeboah, Punyasloke Bhadury, David Kothamasi, Niraj Agarwala, Sukumar Debnath, Thilina Surasinghe, Frank Ashwood, Tushar Kumar, Pawan Kumar, Samina Siddiqui, Jane Gicheha, Petr Heděnec, Rachid Sabbahi, Jasper Wubs, Zhuang Ge, Andrey Zaitsev, Loris Galli, Sunil Mundra, Prabavathy Vaiyapuri Ramalingam, Kate Buckeridge, Partha Pratim Chakravorty, Raquel Juan‐Ovejero, Tobias Pfingstl, Samuel Eziuzor, David Elliott, Derrick Y. F. Lai, Sören Thiele‐Bruhn, Guille Peguero, Nandan Bhattacharyya, Samuel Bonnett, Isimemen Osemwegie, Davorka Hackenberger Kutuzović, Israel Ikoyi, Hamada Abdelrahman, Antonietta La Terza, Mourad Bendada, Konstantin Gongalsky, María Laura Moreno, Daniel Blackburn, Luís Carlos Iunes Oliveira Filho, Stefano Taiti, Maria Fernanda Cordova Hernandez, Leandro Fonseca deSouza, Ingeborg Klarenberg, Marta Novo, Matthieu Chauvat, Ana Ribeiro‐Barros, Kari E. Dunfield, Giuliana Shelly Lizana Flores, Sumit Rai, Shankar Ganapathi Shanmugam, Brett Hale, Dinesh Govindaraj Kamalam, Luis Wall, Maria J. I. Briones, Ji‐Zheng He, Rakesh Kumar, Reza Ghaderi, Radhika Sharma, María Gómez‐Brandón, Muhammad Imtiaz Rashid, Maria Pappas, Louise Egerton‐Warburton, Katalin Szlavecz, Luigimaria Borruso, Giulia Bongiorno, Christina Birnbaum, Samson Mang'oka, Raza Khan, Chiara Alisi, Levan Mumladze, Victoria Burton, Nasir Bashir Naikoo, Marc Dumont, Lidia Oktaba, Olaf Schmidt, El Hassan Mayad, Karin Jacobs, Chidozie Ernest, Dhananjaya Bhakthanakatte Chandrappa, Sol Santander‐Mendoza, Lenin Medina‐Orozco, Michael Schloter, Leigh Winowiecki, Erica Lumini, Cristina C. Bastias, Matthew Bakker, Laura Zucconi, Fabiana Canini, Maria Tsiafouli, Mohd Afzanizam Muda, Sud Sair Sierra, Raul Hernando Posada, Carlo Jacomini, Myo Thant, Deborah A. Neher, Anne Nurbaity, Maika Daveta, Robabeh Latif, Atabak Roohi Aminjan, Hilmar N. Thordarson, Moussa Tady Diallo, Becky Ball, Sina Adl, Zoë Lindo +127 moredoaj +1 more sourceThe role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
Molecular Oncology, EarlyView.The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti +11 morewiley +1 more sourceIMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion
Molecular Oncology, EarlyView.Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd +9 morewiley +1 more sourceTranscriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients
Molecular Oncology, EarlyView.RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel +14 morewiley +1 more sourceSolving Real-Life Problems: Future Mobile Technology Sophistication [PDF]
Mehran University Research Journal of Engineering and Technology, 2016 Almost all the human being real life concerned domains are taking advantage of latest technologies for
enhancing their process, procedures and operations. This integration of technological innovations provides
ease of access, flexibility, transparency, FARHAN SHAFIQ, KAMRAN AHSAN, ADNAN NADEEM +2 moredoaj Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi +19 morewiley +1 more sourceUSP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer
Molecular Oncology, EarlyView.We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra +16 morewiley +1 more sourceFinding novel vulnerabilities of hypomorphic BRCA1 alleles
Molecular Oncology, EarlyView.Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer +10 morewiley +1 more source